|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06833 SINCO PHARMA
Nominal 
0.177 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 2,821,321 | 11.073% | 2,540,063 | 2,271,505 | 2,024,055 | 2,049,803 |
| Cost of Sales | (2,521,380) | 13.740% | (2,216,783) | (1,965,637) | (1,659,105) | (1,775,977) |
| Gross Profit | 299,941 | -7.219% | 323,280 | 305,868 | 364,950 | 273,826 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (4,922) | 64.067% | (3,000) | (2,354) | 164 | (48) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 98,920 | -0.962% | 99,881 | 99,292 | 167,387 | 135,955 | |
| Taxation | (56,875) | -1.137% | (57,529) | (29,830) | (32,304) | (17,818) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 42,045 | -0.725% | 42,352 | 69,462 | 135,083 | 118,137 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 10,529 | 24.353% | 8,467 | 15,911 | 27,851 | 6,848 |
| Depreciation & Amortisation | 24,495 | 50.101% | 16,319 | 11,356 | 6,699 | 9,419 |
| Directors' Emoluments | -- | -- | 9,384 | 4,872 | 3,121 | 2,871 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 2.000 | -4.762% | 2.100 | 3.400 | 7.800 | 7.000 |
| DPS (cts) | 0.185 | -- | 0.354 | 0.858 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 9.270% | -- | 16.840% | 25.231% | -- | -- |
| Cash flow per share ($) | -- | -- | 0.174 | 0.037 | 0.176 | 0.081 |
| NBV per share ($) | 0.326 | -- | 0.309 | 0.297 | 0.200 | 0.098 |
| Remarks: | Real time quote last updated: 16/04/2025 08:35 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 42,045 |
| %Change | -0.725% |
| EPS / (LPS) | RMB 0.020 |
| NBV Per Share (¥) | RMB 0.326 |